Breaking News

Lilly Investing $3B to Expand Acquired Mfg. Facility in Wisconsin

The expanded facility will focus on manufacturing injectable medicines, device assembly and packaging for medicines across multiple therapeutic areas.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Eli Lilly and Co. is investing $3 billion to expand its recently acquired manufacturing facility in Kenosha County, WI. This investment will extend the company’s global parenteral product manufacturing network to support its diabetes, obesity and future pipeline medicines across therapeutic areas. Lilly expects to add 750 highly skilled jobs to the current 100-plus workforce at this location.   The expanded facility will focus on manufacturing injectable medicines, device assembly and pa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters